U.S. Biotech Investment Trend Q1 2026: Capital Overview

As Q3 2026 gets underway, many of the investment trends that emerged earlier this year continue to shape the biotech landscape. This week, we examine how licensing, M&A, and global partnerships have become key drivers of capital allocation, and what these deals reveal about where companies are placing their strategic bets.

Check out the full article here!